Cat. No. | Product name | CAS No. |
DC60103 |
PSMA11
Featured
PSMA-11, also known as DKFZ-PSMA-11, HBED-CC-PSMA or Psma-hbed-CC, is a ligand to make gallium Ga 68-labeled PSMA-11, which has potential use as a tracer for PSMA-expressing tumors during positron emission tomography (PET). Upon intravenous administration of gallium Ga 68-labeled PSMA-11, the Glu-urea-Lys(Ahx) moiety targets and binds to PSMA-expressing tumor cells. Upon internalization, PSMA-expressing tumor cells can be detected during PET imaging. PSMA, a tumor-associated antigen and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells |
1366302-52-4 |
DC60104 |
Episilvestrol
Featured
Episilvestrol, a derivative of silvestrol, is isolated from the fruits and twigs of Aglaia silvestris, Episilvestrol exhibited potent in vitro cytotoxic activity |
697235-39-5 |
DC60105 |
SEN 12333
Featured
SEN-12333, also known as WAY-31753, is is a selective agonist of the alpha(7) nAChR (EC50 = 1.6 μM, Ki = 260 nM at rat α7 nAChRs). SEN-12333 displayed excellent in vitro and in vivo profiles, excellent brain penetration and oral bioavailability, and demonstrates in vivo efficacy in multiple behavioural cognition models. |
874450-44-9 |
DC60106 |
MC-Ala-Ala-Asn(Trt)-PAB
Featured
MC-Ala-Ala-Asn(Trt)-PAB, is a hetero bifunctional cross-linker, useful in antibody drug conjugation (ADC). MC-Ala-Ala-Asn(Trt)-PAB is a fissionable linker which is specifically activated in a tumor microenvironment. XQN70430 was reported in patent WO 2016026458. |
1638970-43-0 |
DC60107 |
MUN36378
Featured
MUN36378 is a FTO inhibitor for treatment of leukemia. This compound was first reported in patent WO 2018157842. This product has no formal name at the moment. For the convenience of communication, a temporal code name was therefore proposed according to MedKoo Chemical Nomenclature. |
2243736-37-8 |
DC60108 |
AZ-7550 Mesylate
Featured
AZ7550 Mesylate is an active metabolite of AZD9291 (Osimertinib) and inhibits the activity of IGF1R with an IC50 of 1.6 μM. |
2319837-99-3 |
DC60109 |
Brevifolincarboxylic acid
Featured
Brevifolincarboxylic acid is extracted from Polygonum capitatum, has inhibitory effect on the aryl hydrocarbon receptor (AhR). Brevifolincarboxylic acid has anticancer and anti-inflammatory activities |
18490-95-4 |
DC60110 |
CAY10781
Featured
CAY10781 is an inhibitor of the protein-protein interaction between NRP-1 and VEGF-A |
1210360-87-4 |
DC60111 |
Gallein( Pyrogallol phthalein )
Featured
Gallein (Pyrogallol phthalein) 是一种可抑制 G protein βγ (G beta-gamma complex, Gβγ) 亚基与 PI3 kinase 相互作用的抑制剂。Gallein 抑制β-ionone的作用并表现出抗肿瘤活性。Gallein 可以用作生物染色剂。 |
2103-64-2 |
DC60112 |
Ginkgolic acid C17:1
Featured
Ginkgolic acid C17:1 (GAC 17:1) 通过废除上游的 JAK2 和 Src 来抑制 STAT3 的组成性激活。Ginkgolic acid C17:1 可以诱导 PTEN 和 SHP-1 的大量表达。Ginkgolic acid C17:1 诱导肿瘤细胞凋亡。 |
111047-30-4 |
DC46199 |
DBCO-PEG4-Ahx-DM1
Featured
DBCO-PEG4-Ahx-DM1 is a drug-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody drug conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. |
2479378-44-2 |
DC46237 |
THK-5470(THK5470)
Featured
THK-5470(THK 5470), a monoamine oxidase-B (MAO-B) imaging probe, could be used for neurological diseases study. THK-5470 shows remarkably high binding affinity against MAO-B with an IC50 value of 4.2 nM, low binding affinity against tau with an IC50 value of 4462 nM. THK-5470 has high selective binding property and high affinity (from patent EP2019-846498). |
2410554-04-8 |
DC46241 |
GPR40/FFAR1 modulator 1(WUN55267)
Featured
GPR40/FFAR1 modulator 1 is an agonist and an allosteric modulator for Gq-coupled free fatty acid receptor 1 (GPR40/FFAR1). |
874755-26-7 |
DC46276 |
BRD0639
Featured
BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction. BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities. |
|
DC46283 |
Sibiromycin
Featured
Sibiromycin is a naturally produced glycosylated pyrrolobenzodiazepines (PBDs). Sibiromycin is also a potent antitumor antibiotic that binds covalently to DNA in the minor groove at the NH2 of guanine. |
12684-33-2 |
DC46309 |
Boc-piperazine-benzoic acid
Featured
Boc-piperazine-benzoic acid is a PROTAC linker and can be used in the synthesis of PROTACs, such as PROTAC androgen receptor (AR) degrader ARD-2128. |
162046-66-4 |
DC46336 |
Wnt/β-catenin agonist 1
Featured
Wnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC50 of 0.27 μM. |
2305372-67-0 |
DC46349 |
ALS-I
Featured
ALS-I, an acid-Liable surfactant, is adopted for in-solution enzymatic digestions, can help to solubilize hydrophobic proteins. ALS-I is significantly enhanced peptide recovery for mass spectrometry (MS) mapping in the study of the proteomes of regenerating rat retina and mouse brain. |
308818-13-5 |
DC46358 |
CCF0058981
Featured
CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CLpro (SC2) inhibitor with an IC50 of 68 nM. CCF0058981 inhibits SC1 (SARS-CoV-1 3CLpro) with an IC50 of 19 nM. CCF0058981 has antiviral efficacy and has the potential for COVID-19 research. |
2708934-53-4 |
DC46369 |
GSK215
Featured
GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader. GSK215 is designed by a binder for the VHL E3 ligase and the FAK inhibitor VS-4718. GSK215 induces rapid and prolonged FAK degradation, giving a long-lasting effect on FAK levels and a marked pharmacokinetic/pharmacodynamics (PK/PD) disconnect. |
2743427-26-9 |
DC46373 |
TP0586532
Featured
TP0586532 is a non-hydroxamate LpxC inhibitor (IC50=0.101 μM). TP0586532 as a compound with a low cardiovascular risk that is effective against K. pneumoniae, including resistant strains. |
2427584-96-9 |
DC46377 |
ML-SA1
Featured
ML-SA1, as a selective TRPML agonist, inhibits Dengue virus 2 (DENV2) and Zika virus (ZIKV) by promoting lysosomal acidification and protease activity. The IC50 value of ML-SA1 against DENV2 RNA and ZIKV RNA is 8.3 μM and 52.99 μM, respectively. ML-SA1 induces autophagy. ML-SA1 can be used for the research of broad-spectrum antiviral. |
332382-54-4 |